10,142 Shares in Cabot Corporation $CBT Bought by Legato Capital Management LLC

Legato Capital Management LLC bought a new position in shares of Cabot Corporation (NYSE:CBT) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 10,142 shares of the specialty chemicals company’s stock, valued at approximately $672,000.

A number of other hedge funds have also bought and sold shares of CBT. NewEdge Advisors LLC raised its stake in Cabot by 2,559.5% during the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after buying an additional 947 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in Cabot by 32.5% during the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after buying an additional 108,645 shares during the last quarter. Empowered Funds LLC raised its stake in Cabot by 102.6% during the first quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock worth $2,341,000 after buying an additional 14,260 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Cabot by 3.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock worth $10,145,000 after buying an additional 4,048 shares during the last quarter. Finally, Geneos Wealth Management Inc. raised its stake in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. UBS Group increased their target price on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Friday, May 8th. Mizuho increased their target price on shares of Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. JPMorgan Chase & Co. increased their target price on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Finally, Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $80.25.

Cabot Stock Up 1.7%

Shares of NYSE CBT opened at $84.80 on Wednesday. The firm has a market cap of $4.38 billion, a PE ratio of 16.03, a P/E/G ratio of 10.91 and a beta of 0.78. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $86.43. The company’s fifty day simple moving average is $76.48 and its 200 day simple moving average is $71.70. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51.

Cabot (NYSE:CBT) last issued its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.31 million. During the same period in the prior year, the firm earned $1.90 earnings per share. Cabot’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, sell-side analysts forecast that Cabot Corporation will post 6.32 earnings per share for the current fiscal year.

Cabot Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be paid a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. This is a positive change from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date of this dividend is Friday, May 29th. Cabot’s payout ratio is 34.03%.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.